WO2002012470A3 - A member of the lysyl oxidase gene family - Google Patents

A member of the lysyl oxidase gene family Download PDF

Info

Publication number
WO2002012470A3
WO2002012470A3 PCT/US2001/024942 US0124942W WO0212470A3 WO 2002012470 A3 WO2002012470 A3 WO 2002012470A3 US 0124942 W US0124942 W US 0124942W WO 0212470 A3 WO0212470 A3 WO 0212470A3
Authority
WO
WIPO (PCT)
Prior art keywords
lysyl oxidase
gene family
oxidase gene
protein
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/024942
Other languages
French (fr)
Other versions
WO2002012470A2 (en
Inventor
Mark J Evans
Marshall S Scicchitano
Ashok R Bapat
Eric Beer
Ramesh A Bhat
Elissa Ferris
Robert Mastroeni
Jianziong Zhang
Sotirios K Karathanasis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to HK04102872.5A priority Critical patent/HK1060148B/en
Application filed by Wyeth LLC filed Critical Wyeth LLC
Priority to AU2001284769A priority patent/AU2001284769A1/en
Priority to CA002418952A priority patent/CA2418952A1/en
Priority to DE60128830T priority patent/DE60128830T2/en
Priority to MXPA03001196A priority patent/MXPA03001196A/en
Priority to JP2002517761A priority patent/JP2004505631A/en
Priority to EP01963850A priority patent/EP1354046B1/en
Priority to BR0113257-1A priority patent/BR0113257A/en
Priority to IL15403601A priority patent/IL154036A0/en
Publication of WO2002012470A2 publication Critical patent/WO2002012470A2/en
Anticipated expiration legal-status Critical
Publication of WO2002012470A3 publication Critical patent/WO2002012470A3/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0014—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4)
    • C12N9/0022—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a novel lysyl oxidase genes, termed EER-7. The invention relates to the protein and nucleic acids encoding the protein. The invention further relates to an assay system to identify compounds that selectively modulate EER-7 protein activity by interaction with estrogen receptors.
PCT/US2001/024942 2000-08-08 2001-08-08 A member of the lysyl oxidase gene family Ceased WO2002012470A2 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
BR0113257-1A BR0113257A (en) 2000-08-08 2001-08-08 Protein eer-7 of the lysyl oxidase gene family, method for producing it, detecting and detecting its expression, polypeptide fragment thereof, isolated nucleic acid and vector comprising the same, and assay system
AU2001284769A AU2001284769A1 (en) 2000-08-08 2001-08-08 A member of the lysyl oxidase gene family
CA002418952A CA2418952A1 (en) 2000-08-08 2001-08-08 A novel member of the lysyl oxidase gene family
DE60128830T DE60128830T2 (en) 2000-08-08 2001-08-08 REGULATION OF THE EXPRESSION OF EER-7, A MEMBER OF THE LYSYL OXIDASE GENE FAMILY, BY ORESTROGEN RECEPTORS
MXPA03001196A MXPA03001196A (en) 2000-08-08 2001-08-08 A novel member of the lysyl oxidase gene family.
HK04102872.5A HK1060148B (en) 2000-08-08 2001-08-08 Regulation of expression of eer-7, a member of the lysyl oxidase gene family, by estrogen receptors
EP01963850A EP1354046B1 (en) 2000-08-08 2001-08-08 Regulation of expression of eer-7, a member of the lysyl oxidase gene family, by estrogen receptors
JP2002517761A JP2004505631A (en) 2000-08-08 2001-08-08 A new member of the lysyl oxidase gene family
IL15403601A IL154036A0 (en) 2000-08-08 2001-08-08 A novel member of the lysyl oxidase gene family

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US22376300P 2000-08-08 2000-08-08
US60/223,763 2000-08-08
US25583800P 2000-12-15 2000-12-15
US60/255,838 2000-12-15

Publications (2)

Publication Number Publication Date
WO2002012470A2 WO2002012470A2 (en) 2002-02-14
WO2002012470A3 true WO2002012470A3 (en) 2003-08-28

Family

ID=26918106

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/024942 Ceased WO2002012470A2 (en) 2000-08-08 2001-08-08 A member of the lysyl oxidase gene family

Country Status (11)

Country Link
US (2) US7208300B2 (en)
EP (1) EP1354046B1 (en)
JP (1) JP2004505631A (en)
AT (1) ATE364087T1 (en)
AU (1) AU2001284769A1 (en)
BR (1) BR0113257A (en)
CA (1) CA2418952A1 (en)
DE (1) DE60128830T2 (en)
IL (1) IL154036A0 (en)
MX (1) MXPA03001196A (en)
WO (1) WO2002012470A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030114410A1 (en) * 2000-08-08 2003-06-19 Technion Research And Development Foundation Ltd. Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
US8119599B2 (en) * 2001-08-31 2012-02-21 Orthopeutics, L.P. Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity
US20070225242A1 (en) * 2005-06-21 2007-09-27 The Board Of Trustees Of The Leland Stanford Junior University Method and composition for treating and preventing tumor metastasis in vivo
US20070021365A1 (en) * 2005-06-21 2007-01-25 The Board Of Trustees Of The Leland Stanford Junior University Inhibition of Lysyl oxidase for treating tumor growth and diagnostics relating thereto
US9687262B2 (en) * 2005-11-30 2017-06-27 CARDINAL HEALTH SWITZERLAND 515 GmbH Methods and devices for treating vulnerable plaque
US10278947B2 (en) 2007-02-28 2019-05-07 Orthopeutics, L.P. Crosslinker enhanced repair of connective tissues
ES2700141T3 (en) 2007-08-02 2019-02-14 Gilead Biologics Inc LOXL2 inhibitory antibodies and their uses
WO2010080769A2 (en) * 2009-01-06 2010-07-15 Arresto Biosciences, Inc. Chemotherapeutic methods and compositions
BR112012008084A2 (en) * 2009-08-21 2019-09-24 Gilead Biologics Inc therapeutic methods and compositions.
SG178845A1 (en) * 2009-08-21 2012-04-27 Gilead Biologics Inc Catalytic domains from lysyl oxidase and loxl2
WO2011022670A1 (en) * 2009-08-21 2011-02-24 Arresto Biosciences, Inc In vivo screening assays
WO2011022709A1 (en) * 2009-08-21 2011-02-24 Arresto Biosciences, Inc In vitro screening assays
NZ625850A (en) * 2009-08-21 2015-12-24 Gilead Biologics Inc Methods and compositions for treatment of pulmonary fibrotic disorders
BR112012019693A2 (en) 2010-02-04 2017-06-20 Gilead Biologics Inc antibodies that bind to lysyl oxidase-like 2 (loxl2) and methods of use for them.

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5945279A (en) * 1991-05-02 1999-08-31 Baylor College Of Medicine Screening system for identifying compounds that regulate steroid and orphan receptors mediation of DNA transcription
WO2000037681A1 (en) * 1998-12-18 2000-06-29 American Home Products Corporation BIOASSAY FOR IDENTIFYING ESTROGEN RECEPTOR-β/α SELECTIVE MODULATORS
WO2000061774A2 (en) * 1999-04-09 2000-10-19 Human Genome Sciences, Inc. Bone morphogenic proteins
WO2001083702A2 (en) * 2000-05-03 2001-11-08 University Of Hawaii Novel members of the lysyl oxidases family of amine oxidases related applications
WO2001092495A2 (en) * 2000-05-26 2001-12-06 Millennium Pharmaceuticals, Inc. A human lysyl ixodase (47765) and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7264926B2 (en) * 2000-04-18 2007-09-04 Millennium Pharmaceuticals, Inc. Nucleoside Phosphatase

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5945279A (en) * 1991-05-02 1999-08-31 Baylor College Of Medicine Screening system for identifying compounds that regulate steroid and orphan receptors mediation of DNA transcription
WO2000037681A1 (en) * 1998-12-18 2000-06-29 American Home Products Corporation BIOASSAY FOR IDENTIFYING ESTROGEN RECEPTOR-β/α SELECTIVE MODULATORS
WO2000061774A2 (en) * 1999-04-09 2000-10-19 Human Genome Sciences, Inc. Bone morphogenic proteins
WO2001083702A2 (en) * 2000-05-03 2001-11-08 University Of Hawaii Novel members of the lysyl oxidases family of amine oxidases related applications
WO2001092495A2 (en) * 2000-05-26 2001-12-06 Millennium Pharmaceuticals, Inc. A human lysyl ixodase (47765) and uses thereof

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 12 February 2000 (2000-02-12), XP002211809, Database accession no. AL139241 *
DAVIS VICKI L ET AL: "Aberrant reproductive phenotypes evident in transgenic mice expressing the wild-type mouse estrogen receptor.", ENDOCRINOLOGY, vol. 135, no. 1, 1994, pages 379 - 386, XP008008475, ISSN: 0013-7227 *
ITO HIROMU ET AL: "Molecular cloning and biological activity of a novel lysyl oxidase-related gene expressed in cartilage", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 276, no. 26, 29 June 2001 (2001-06-29), pages 24023 - 24029, XP002199860, ISSN: 0021-9258 *
LANGENAU D M ET AL: "The upregulation of messenger ribonucleic acids during 17alpha, 20beta-dihydroxy-4-pregnen-3-one-induced ovulation in the perch ovary.", JOURNAL OF MOLECULAR ENDOCRINOLOGY, vol. 23, no. 2, October 1999 (1999-10-01), pages 137 - 152, XP002211806, ISSN: 0952-5041 *
MORALES D E ET AL: "ESTROGEN PROMOTES ANGIOGENIC ACTIVITY IN HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS IN VITRO AND IN A MURINE MODEL", CIRCULATION, AMERICAN HEART ASSOCIATION, DALLAS, TX, US, vol. 91, no. 3, 1 February 1995 (1995-02-01), pages 755 - 763, XP000574264, ISSN: 0009-7322 *
OZASA H ET AL: "LYSYL OXIDASE ACTIVITY IN THE MOUSE UTERINE CERVIX IS PHYSIOLOGICALLY REGULATED BY ESTROGEN", ENDOCRINOLOGY, vol. 109, no. 2, 1981, pages 618 - 621, XP008007638, ISSN: 0013-7227 *
SAITO H ET AL: "Regulation of a novel gene encoding a lysyl oxidase-related protein in cellular adhesion and senescence", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 272, no. 13, 28 March 1997 (1997-03-28), pages 8157 - 8160, XP002187526, ISSN: 0021-9258 *
SANADA H ET AL: "CHANGES IN COLLAGEN CROSS LINKING AND LYSYL OXIDASE BY ESTROGEN", BIOCHIMICA ET BIOPHYSICA ACTA, vol. 541, no. 3, 1978, EN, pages 408 - 413, XP008007649, ISSN: 0006-3002 *

Also Published As

Publication number Publication date
DE60128830T2 (en) 2008-01-31
EP1354046A2 (en) 2003-10-22
EP1354046B1 (en) 2007-06-06
ATE364087T1 (en) 2007-06-15
AU2001284769A1 (en) 2002-02-18
BR0113257A (en) 2003-10-28
US7445920B2 (en) 2008-11-04
US20040171110A1 (en) 2004-09-02
US20020102645A1 (en) 2002-08-01
JP2004505631A (en) 2004-02-26
WO2002012470A2 (en) 2002-02-14
US7208300B2 (en) 2007-04-24
DE60128830D1 (en) 2007-07-19
IL154036A0 (en) 2003-07-31
HK1060148A1 (en) 2004-07-30
MXPA03001196A (en) 2004-04-05
CA2418952A1 (en) 2002-02-14

Similar Documents

Publication Publication Date Title
WO2002012470A3 (en) A member of the lysyl oxidase gene family
WO2001075145A3 (en) Ubiquitin ligase assay
WO2003052110A3 (en) Nucleic acid nematicides
WO1999057325A3 (en) Enzymes mixture
WO2001036641A3 (en) DOUBLE-STRANDED RNA RECEPTOR (dsRNA-R) AND METHODS RELATING THERETO
WO2002038806A3 (en) Detection of nucleic acid polymorphisms
WO2002029075A8 (en) Multiple inducible gene regulation system
AU2003241311A1 (en) Simple catalytic dna biosensors for ions based on color changes
WO2002004488A3 (en) Nucleic acid binding polypeptides
WO1999013085A3 (en) MICROBIAL GENES FOR SECRETED β-GLUCURONIDASES, GENE PRODUCTS AND USES THEREOF
WO2001019861A3 (en) Apo-2 receptor antibodies
AU1727597A (en) Purified sr-p70 protein
WO2000028043A3 (en) Polypeptides having lactonohydrolase activity and nucleic acids encoding same
AU2002362800A1 (en) Modulation of the expression of genes dependent on stat-1
ATE500338T1 (en) USE OF THE ADENOVIRAL E2-LATE PROMOTER
WO1998046768A3 (en) Phenolic acid esterase and use thereof
AU2002326361A1 (en) Nucleic acid detection assay control genes
DE60130394D1 (en) Genes related to the biosynthesis of ML-236B
AU2002231194A1 (en) G protein-coupled receptor protein and nucleic acid molecules and uses therefor
AU9314798A (en) Ccr5 rna transcription based amplification assay
AU2438501A (en) Expression of proteins from amplified, immobilized nucleic acids
WO2001074902A3 (en) Adenine binding g protein coupled receptors
EP1213351A3 (en) Nucleic acid enzymes acquiring an activity for cleaving a target RNA by recognising another molecule
WO2000052179A3 (en) Dna binding compound-mediated molecular switch system
WO2000023592A3 (en) Minimal promoters and uses thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 154036

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2001963850

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2418952

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: PA/a/2003/001196

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 2002517761

Country of ref document: JP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2001963850

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 2001963850

Country of ref document: EP